Sharps Technology Inc
sharpstechnology.comSharps Technology Inc (NASDAQ: STSS) is a medical device and digital asset company that markets and distributes syringe products while holding Solana (SOL) cryptocurrency as its primary treasury reserve asset. Revenue is generated through product sales of disposable syringe inventory and staking rewards earned from SOL holdings. Following a settlement agreement executed on October 6, 2025, the company transferred its Hungarian subsidiary Safegard Medical Kft and certain patents to Plasto Technology Group LLC, exited its research and development activities, and reoriented as a medical device sales and distribution enterprise. As of December 31, 2025, the company held over 2.0 million SOL tokens, allocated under a Treasury Policy approved by its Board of Directors on December 20, 2025. Target customers for syringe products include foreign governments, hospitals, and healthcare groups. The company has no disclosed dominant market position among syringe distributors, and the filing names no direct competitors.
Products & Services
Disposable syringe products (existing inventory held for distribution); Solana (SOL) digital asset holdings used for staking and treasury reserve; SOL-based call and put options disclosed as part of treasury strategy.
Revenue Model
Product sales of disposable syringe inventory (transactional) and Solana staking rewards (SOL staked with validators on the proof-of-stake Solana network), per the FY2025 10-K filed 2026-03-31.
Customers & Markets
Prospective customers for syringe products include foreign governments, hospitals, and healthcare groups. The company is in ongoing discussions with healthcare companies and distributors as of the FY2025 filing. No customer concentration data disclosed.
Geographic Exposure
U.S.-headquartered. Hungarian subsidiary Safegard Medical Kft was transferred to Plasto Technology Group LLC pursuant to the October 6, 2025 settlement agreement, exiting direct European operations.
Financial Snapshot
Loading...
